Review Finds 140 Controlled Clinical Trials Of Cannabis
Cannabis has met the “gold standard” of scientific review. Scientists have conducted more than 140 controlled clinical trials since 1975 assessing the safety and efficacy of either whole-plant cannabis or specific cannabinoids, according to a literature review published in the journal Critical Reviews in Plant Sciences.
Thousands more studies have met lesser standards and, throughout most of the 47 years since the Controlled Substances Act was adopted, the federal government has provided about 6.65 pounds per year of medical marijuana to patients in its IND program. Oh, and the Feds also hold a patent on medical marijuana, which they say has no medical value.
We don’t even need to get into any of that to show that the DEA has misclassified cannabis as a Schedule 1 drug, even under the most stringent standards of modern science, double-blinded controlled clinical trials.
Cannabis for pain most tested therapy
A pair of German researchers identified 140 clinical trials involving an estimated 8,000 participants. Of these, the largest body of literature focuses on the use of cannabis or cannabinoids for the treatment of chronic or neuropathic pain. Authors identified 35 controlled studies, involving 2,046 subjects, assessing the use of marijuana or cannabinoids in pain management.
In January, the National Academy of Sciences acknowledged that “conclusive or substantial evidence” exists for cannabis’ efficacy in patients suffering from chronic pain.
Many other medical uses documented
Cannabinoids have also been well studied as anti-emetic agents and as appetite stimulants. Researchers identified 43 trials evaluating marijuana or its components for these purposes, involving a total of 2,498 patients. They identified an additional 14 trials examining the role of cannabis or cannabis-derived extracts for the treatment of multiple sclerosis.
Continue reading at theleafonline.com
Don’t forget to like and subscribe to WeedTV @yourweedtv